Edgewise Therapeutics, Inc.

EWTX·NasdaqGS·Healthcare
Compare
37.53−0.15 (−0.40%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close37.68
Open38.96
Day range37.3939.48
52-week range16.7048.51
Off day high−4.94%
Off 52-week high−22.63%
Volume1.03M
Avg. volume (3M)1.41M
Market cap4.08B
EPS (TTM)-1.86
Forward P/E-20.08
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.40
Shares outstanding108.60M
Short interest15.25% of float
Earnings dateNov 4, 2026
Analyst target54.00
Profit margin0.00%

Against its peers

Compare in full ›
EWTX SLDB CYTK IONS PTCT B9A.F
Market cap 4.08B 699.11M 8.84B 6.67B 5.76B 2.45B
P/E (TTM) — — — — — 250.7
Forward P/E -20.1 -3.8 -14.4 -35.0 28.4 —
Price/book 7.6 2.9 -11.9 15.1 -30.1 1.2
Dividend yield — — — — — 0.68%
1-year change +119.60% +54.69% +5.47% −45.82% −5.09% +13.08%
Today −0.40% +3.82% +2.07% −0.67% +1.25% −0.29%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Edgewise Therapeutics's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Solid Biosciences Inc.SLDB · Biotechnology 699.11M 6.52 +3.82%
Cytokinetics, IncorporatedCYTK · Biotechnology 8.84B 63.60 +2.07%
Ionis Pharmaceuticals, Inc.IONS · Biotechnology 6.67B 40.15 −0.67%
PTC Therapeutics, Inc.PTCT · Biotechnology 5.76B 68.97 +1.25%
BioArctic AB (publ)B9A.F · Biotechnology 2.45B 27.58 −0.29%
Design Therapeutics, Inc.DSGN · Biotechnology 665.24M 10.63 +2.80%
BridgeBio Pharma, Inc.BBIO · Biotechnology 15.17B 77.89 +5.21%
Biohaven Ltd.BHVN · Biotechnology 2.30B 15.24 −2.37%

Also based in Boulder, Colorado, then elsewhere in Colorado.

Company Mkt cap Price Today
Enliven Therapeutics, Inc.ELVN · Boulder, CO 3.46B 47.25 +5.40%
Gloo Holdings, Inc.GLOO · Boulder, CO 268.49M 2.9000 0.00%
OnKure Therapeutics, Inc.OKUR · Boulder, CO 104.89M 2.5900 +3.60%
Laird Superfood, Inc.LSF · Boulder, CO 26.86M 2.4000 −4.76%
Sonoma Pharmaceuticals, Inc.SNOA · Boulder, CO 5.32M 1.1100 −2.63%
Auddia Inc.AUUD · Boulder, CO 4.58M 0.7890 −3.31%
Newmont CorporationNEM · Denver, CO 122.74B 118.11 +9.90%
AngloGold Ashanti plcAU · Greenwood Village, CO 44.46B 87.91 +7.98%

The stocks whose daily moves over the past year went most closely with Edgewise Therapeutics's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Cytokinetics, IncorporatedCYTK · Correlation 0.40 8.84B 63.60 +2.07%
Solid Biosciences Inc.SLDB · Correlation 0.39 699.11M 6.52 +3.82%
Tango Therapeutics, Inc.TNGX · Correlation 0.33 3.91B 23.18 +0.04%
Monte Rosa Therapeutics, Inc.GLUE · Correlation 0.31 923.09M 10.82 +3.94%
PTC Therapeutics, Inc.PTCT · Correlation 0.31 5.76B 68.97 +1.25%

What visitors to Edgewise Therapeutics's page also look at.

Company Mkt cap Price Today
Design Therapeutics, Inc.DSGN 665.24M 10.63 +2.80%
Cullinan Therapeutics, Inc.CGEM 767.61M 12.49 −20.70%
Monte Rosa Therapeutics, Inc.GLUE 923.09M 10.82 +3.94%
Tyra Biosciences, Inc.TYRA 1.48B 21.53 +0.73%
IDEAYA Biosciences, Inc.IDYA 3.12B 32.36 +3.29%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All EWTX news ›
TradingView·Positive

Edgewise Therapeutics Reports Third Quarter 2026 Financial Results

– Published the differentiated mechanism of action of EDG-7500 that targets the regulatory light chain – – Phase 3 trial for EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) on track to initiate by year-end 2026…

EWTX
Morningstar··2 outletsPositive

Edgewise Therapeutics Doses First Patient in Phase 2 EQUINOX-HFpEF Trial of EDG-15400

BOULDER, Colo., Oct. 8, 2026 – Phase 2 trial evaluating EDG-15400 in adults with symptomatic HFpEF with a LVEF of at least 50% – – EQUINOX-HFpEF trial design and EDG-15400 Phase 1 first-in-human data to be presented at HFSA 2026 –…

EIKNEWTXEPRX
More from 1 other outlet
MedCity News·

Verve Therapeutics

Eli Lilly is acquiring Beam Therapeutics’ opt-in rights to three Verve Therapeutics gene-editing therapies for cardiovascular conditions. The deal comes four months after the pharmaceutical giant began a partnership on a preclinical Verve…

EWTXRANISPCXLLY
MarketScreener·Positive

Transcript : Edgewise Therapeutics, Inc. - Special Call

Presentation Operator MessageOperator Good morning, and welcome to the Edgewise Therapeutics Research Update. [Operator Instructions] As a reminder, this call is being recorded, and a replay will Transcript : Edgewise Therapeutics, Inc. -…

EWTXABOSARWR

From the 4Search news index, newest first.

In the news

23mentions in 30 days
19with it in the headline
Positivesentiment

Mentioned with

Edgewise Therapeutics, Inc13Edgewise Therapeutics, Inc.9Novo Nordisk8Eli Lilly7Pfizer7U.S. Food and Drug Administration7Wells Fargo 21St Annual Healthcare Conference7Astrazeneca6

People in the coverage

Danessa Lincoln13Ben Burnett6Geoff Meacham6Akebia5H.c. Wainwright5Sarita Garza5

Themes

Healthcare11Therapeutics7Earnings6Biotech5Biotechnology5FDA5Finanzen5Equities4

Most coverage from

  1. marketscreener.com19
  2. prnewswire.com2
  3. medcitynews.com1
  4. tradingview.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 23 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance